|
ENVB Enveric Biosciences Inc 890821 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-3,027,733.00 |
| Balance Sheet |
|
Current Assets
|
$8,793,325.00 |
|
Assets
|
$8,943,999.00 |
|
Current Liabilities
|
$861,475.00 |
|
Equity
|
$8,082,524.00 |
|
Shares Out
|
3935884.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-4,701,378.00 |
|
Investing Cash Flow
|
$11,667.00 |
| Market Analysis |
Market Cap
|
$5,470,878.76 |
|
Price
|
$1.39 |
|
BVPS
|
2.05 |
|
PB
|
0.68 |
|
EPS
|
-0.76 |
|
FCF
|
$-4,706,558.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:03 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:53 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ENVB documents filed with the SEC.
ENVB Filings
Clear
